Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Akershus Cardiac Examination (ACE) 1950 Study
This entry provides an update on the Akershus Cardiac Examination (ACE) 1950 clinical trial, which is currently active but not recruiting. T…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: The Effect of High-Intensity Interval Training on Glucose Variability and Atrial Fibrillation Symptoms [NA]
The trial investigated the effect of high‑intensity interval training on glucose variability and atrial fibrillation symptoms in people with…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
A multicenter prospective study is validating a universal assay to quantify levels of apixaban, rivaroxaban, danaparoid, and fondaparinux.
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)
A completed clinical trial (PANACEA-AF, NCT03737838) from the University of Chicago evaluating propagation analysis to prevent atrial flutte…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Ablation of Focal Activation in Atrial Fibrillation [NA]
Imperial College London is conducting a trial to evaluate ablation of focal activation in atrial fibrillation. Recruitment is ongoing for pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) [Phase 2]
Phase 2 trial evaluating AP30663 for cardioversion in atrial fibrillation has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Lifestyle Intervention Feasibility for Arrhythmia and Symptoms With Intermittent Fasting (LIFE AS IF) [NA]
This completed trial update reports on the feasibility of an intermittent fasting lifestyle program for individuals with obesity and arrhyth…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: STROKESTOP III - Optimized Method for Atrial Fibrillation Screening [NA]
STROKESTOP III is a clinical trial evaluating an optimized method for screening atrial fibrillation and is currently recruiting.
-
FDA approval · 2024-04-30FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sotalol hydrochloride from Aurobindo Pharma Limited, authorizing the generic product's approval.
-
FDA approval · 2024-04-30FDA Approved: DOFETILIDE 0.125MG — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for dofetilide 0.125 mg (granules) by Granules Pharmaceuticals Inc., expanding the product's availab…
-
FDA approval · 2024-04-29FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access [NA]
Clinical trial update on the AThrough radiofrequency transseptal puncture system for left atrial access; the study has completed.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation [NA]
The document reports a clinical trial exploring cryoballoon ablation as the initial treatment for persistent atrial fibrillation, with the c…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
This clinical trial update reports the completion of a study evaluating a 1-lead ECG device to relieve the emergency department burden for a…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: Epigenetic Analysis of Regulation of the Inflammasome-activating NLRP3 Gene in Monocytes From Atrial Fibrillation Patients and Controls
This clinical-trial update describes a completed study analyzing epigenetic regulation of the inflammasome-activating NLRP3 gene in monocyte…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care [Phase 3]
This clinical trial update describes a Phase 3 study (MAGNAM) comparing magnesium sulfate to amiodarone for new-onset atrial fibrillation in…
-
FDA approval · 2024-04-23FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (FRESENIUS KABI USA, LLC)
FDA approved the original application for Verapamil hydrochloride as a generic drug, manufactured by Fresenius Kabi USA, LLC. Verapamil hydr…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG [Phase 3]
Phase 3 clinical trial investigating calcium chloride injection to alleviate atrial fibrillation after coronary artery bypass grafting is cu…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Persistent Atrial Fibrillation (AF) APAC (Asia Pacific) Observational Study
An Asia-Pacific observational study on persistent atrial fibrillation sponsored by Abbott Medical Devices has terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: INtra-procedural ultraSound Imaging During Pulmonary Veins Isolation
A clinical trial evaluating intra-procedural ultra-sound imaging during pulmonary veins isolation for atrial fibrillation has completed with…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery [Phase 2]
Phase 2 trial updating safety of non-vitamin K oral anticoagulants versus warfarin early after cardiac surgery in atrial fibrillation patien…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Lixiana Acute Stroke Evaluation Registry [Phase 4]
Phase 4 clinical trial update for Lixiana (edoxaban) Acute Stroke Evaluation Registry; completed study evaluating ischemic stroke in the con…
-
FDA approval · 2024-04-01FDA Approved: IBUTILIDE FUMARATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original ANDA for ibutilide fumarate (generic) from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: AMPLATZER™ LAA Occluder Post Approval Study (PAS)
This is a post-approval study update for the AMPLATZER LAA Occluder, reporting completed results and posted findings.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: HD Mapping of Atrial Fibrillation in Asia Pacific
A completed clinical trial update on HD mapping for atrial fibrillation in Asia Pacific with results posted in 2024.